Some people report positive results with other treatments, but those with true pernicious anemia are unlikely to benefit at all
The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours)
These injections may also be unsuitable for those with hypovolemic shock or muscle wasting, as these conditions affect drug absorption.
But I also think that there are places, such as with experimental treatments like with BPC-157, we probably need to press pause on at least until theres some actual human trials that trend towards FDA approval and keep things where they are today
It refers to the inclusion of a preservative that helps limit the growth of bacteria during handling
Is support healing processes that dietary changes and acid suppression can't address alone